cronos
group
reports
third
quarter
results
kurt
schmidt
appointed
president
ceo
mike
gorenstein
appointed
executive
chairman
launched
new
cbd
brand
happy
market
partnership
kristen
bell
cronos
israel
received
approval
sell
peace
branded
oils
israel
cronos
device
labs
expands
cannabinoid
research
scope
rebrands
cronos
research
labs
toronto
globe
newswire
cronos
group
nasdaq
cron
tsx
cron
cronos
group
company
today
announces
third
quarter
business
results
opportunities
cronos
group
exciting
ever
honored
brought
company
important
inflection
point
bring
kurt
schmidt
serve
new
president
ceo
said
mike
gorenstein
executive
chairman
cronos
group
look
forward
continuing
launch
innovative
cannabinoid
products
canada
expand
portfolio
cbd
brands
internationally
pleased
progress
made
israel
regulations
continue
evolve
look
establish
leader
markets
operate
short
period
time
mike
cronos
team
achieved
several
impressive
milestones
said
kurt
schmidt
president
ceo
cronos
group
first
cannabis
company
list
nasdaq
scaling
operations
worldwide
cronos
group
continue
thrive
joining
president
ceo
unique
opportunity
bring
expertise
building
outstanding
brands
high
performance
teams
organizations
cronos
group
look
forward
helping
company
achieve
many
exciting
financial
results
thousands
dollars
three
months
ended
september
change
nine
months
ended
september
change
net
revenue
united
states
rest
world
consolidated
net
revenue
gross
profit
loss
gross
margin
pp
pp
reported
operating
loss
adjusted
operating
loss
data
cash
cash
equivalents
ii
investments
ii
capital
expenditures
see
measures
information
including
reconciliation
adjusted
operating
loss
ii
dollar
amounts
last
day
period
indicated
third
quarter
net
revenue
million
increased
million
increase
primarily
driven
continued
growth
canadian
cannabis
market
inclusion
redwood
acquisition
financial
results
growth
israeli
medical
cannabis
market
partially
offset
wholesale
revenue
canadian
market
strategic
price
reductions
various
cannabis
products
certain
canadian
provinces
gross
loss
million
decreased
million
decrease
losses
primarily
driven
increase
net
revenue
gross
profit
contribution
business
segment
offset
increase
cost
sales
primarily
driven
higher
volume
sales
associated
purchased
flower
decline
wholesale
sales
reported
operating
loss
million
increased
million
increase
primarily
driven
increased
payments
related
separation
agreements
certain
redwood
employees
increased
general
administrative
expenses
inclusive
review
costs
costs
related
previously
disclosed
restatement
company
interim
financial
statements
higher
sales
marketing
costs
related
brand
development
r
spending
partially
offset
decrease
gross
loss
business
updates
brand
portfolio
subsequent
end
third
quarter
cronos
group
segment
launched
new
cbd
skincare
personal
care
brand
called
happy
partnership
kristen
bell
happy
products
made
cbd
premium
hemp
extract
provide
consumers
skincare
accessible
price
point
happy
launched
three
product
offerings
whipped
body
butter
coconut
melt
stress
away
bath
bomb
currently
available
online
intentions
enter
brick
mortar
channel
future
partnership
bell
cronos
group
looks
forward
future
introductions
innovative
products
cbd
market
october
segment
also
launched
new
tinctures
cbd
brand
lord
tinctures
available
two
flavors
peppermint
orange
segment
anticipates
launching
lord
branded
cbd
infused
lip
balm
november
whole
plant
formula
cbd
lip
balm
expected
contain
cbd
hemp
extract
premium
ingredients
including
shea
butter
mimosa
wax
beeswax
oil
blend
provide
additional
hydration
global
sales
distribution
cronos
israel
received
certifications
required
cultivation
production
marketing
dried
flower
oils
israel
subsequent
end
third
quarter
addition
peace
branded
dried
flower
currently
sold
israeli
medical
market
cronos
israel
began
selling
peace
branded
oils
israeli
medical
market
global
supply
chain
third
quarter
natuera
continued
successfully
complete
imports
cbd
extract
business
development
r
purposes
natuera
also
completed
first
export
cbd
distillate
united
kingdom
r
purposes
moreover
natuera
subsidiary
colombia
awarded
four
quotas
colombian
government
psychoactive
cannabis
r
production
one
cultivation
quota
conduct
field
trials
characterize
cultivars
ii
one
cultivation
quota
conduct
r
related
manufacture
derivatives
iii
two
r
manufacturing
quotas
analyze
characterize
thc
products
intellectual
property
initiatives
third
quarter
cronos
device
labs
expanded
scope
cannabinoid
research
r
center
renamed
cronos
research
labs
cronos
group
engages
understanding
fundamental
science
behind
interactions
cannabinoids
interactions
leveraged
best
deliver
consumer
needs
additionally
company
partners
leading
scientific
institutions
engaged
fundamental
cannabis
science
augment
accelerate
internal
efforts
cronos
group
work
spans
many
aspects
cannabis
research
strain
development
growing
conditions
extraction
technology
biosynthesis
product
development
supported
advances
analytical
sciences
enterprise
initiatives
third
quarter
company
implemented
new
enterprise
resource
planning
erp
system
across
canadian
business
cronos
group
also
commenced
work
broaden
reach
erp
system
business
currently
expected
launched
first
half
new
erp
system
meaningful
component
company
internal
control
financial
reporting
expected
enable
us
realize
efficiencies
throughout
supply
chain
operations
appointments
september
cronos
group
expanded
leadership
structure
drive
next
phase
growth
appointing
kurt
schmidt
president
chief
executive
officer
move
coincides
mike
gorenstein
appointment
executive
chairman
schmidt
brings
deep
experience
consumer
products
decades
leadership
experience
overseas
schmidt
previously
served
director
chief
executive
officer
blue
buffalo
company
prior
joining
blue
buffalo
schmidt
deputy
executive
vice
president
nestlé
responsible
nestlé
nutrition
including
several
heavily
regulated
businesses
also
served
member
nestlé
executive
committee
schmidt
joined
nestlé
part
nestlé
acquisition
gerber
products
company
president
chief
executive
officer
prior
gerber
schmidt
held
variety
leadership
roles
kraft
foods
inc
addition
company
bolstered
senior
leadership
team
adding
shannon
buggy
senior
vice
president
global
head
people
prior
joining
cronos
group
buggy
senior
vice
president
global
human
resources
nielsen
led
hr
strategy
nielsen
media
years
experience
buggy
proven
track
record
leading
managing
global
human
resources
teams
driving
excellence
talent
acquisition
development
retention
employee
relations
compensation
benefits
talent
management
labor
relations
additionally
quarter
previously
disclosed
following
resignation
robert
rosenheck
july
summer
frein
named
general
manager
usa
frein
joined
cronos
group
january
year
however
worked
cronos
group
various
capacities
since
previously
frein
employed
altria
led
strategy
business
development
team
due
diligence
cannabis
space
culminated
cronos
group
strategic
investment
altria
recently
responsible
leading
company
sales
efforts
including
managing
brand
retail
partnerships
lord
frein
leadership
company
plans
expand
business
including
introducing
new
product
formats
lord
happy
target
different
retail
channels
consumers
update
cronos
group
manufacturing
sites
adjusted
order
comply
current
guidelines
provided
governmental
authorities
third
quarter
effects
significant
number
company
retail
customers
continued
challenged
permanent
temporary
store
closings
stores
open
faced
operating
reduced
staff
levels
reduced
opening
hours
lower
consumer
foot
traffic
continued
third
quarter
negatively
impact
sales
demand
products
segment
revenue
rest
world
segment
materially
impacted
effects
three
nine
months
ended
september
rest
world
results
cronos
group
rest
world
reporting
segment
includes
results
company
operations
markets
outside
thousands
dollars
three
months
ended
september
change
nine
months
ended
september
change
cannabis
flower
cannabis
extracts
net
revenue
gross
profit
loss
gross
margin
pp
pp
reported
adjusted
operating
loss
see
measures
information
including
reconciliation
adjusted
operating
loss
third
quarter
net
revenue
million
increased
million
increase
primarily
driven
continued
growth
canadian
cannabis
market
growth
israeli
medical
cannabis
market
partially
offset
wholesale
revenue
canadian
market
strategic
price
reductions
various
cannabis
products
certain
canadian
provinces
gross
loss
million
decreased
million
decrease
losses
primarily
driven
increase
net
revenue
offset
increase
cost
sales
primarily
driven
higher
volume
sales
associated
purchased
flower
decline
wholesale
sales
company
anticipates
gross
margin
continue
fluctuate
price
mix
change
reported
operating
loss
million
decreased
million
decrease
losses
primarily
driven
decrease
general
administrative
costs
driven
reclassification
million
corporate
expenses
effect
company
consolidated
statement
net
income
loss
decrease
gross
loss
partially
offset
increase
r
spending
united
states
results
cronos
group
reporting
segment
includes
results
company
operations
brands
products
thousands
dollars
three
months
ended
september
change
nine
months
ended
september
change
net
revenue
gross
profit
gross
margin
pp
pp
reported
operating
loss
third
quarter
net
revenue
million
increased
million
increase
primarily
driven
full
quarter
results
opposed
days
gross
profit
million
increased
million
increase
primarily
driven
increase
net
revenue
partially
offset
increased
discounts
sales
promotions
new
product
introductions
reported
operating
loss
million
increased
million
increase
primarily
driven
increase
payments
related
separation
agreements
certain
redwood
employees
increased
sales
marketing
costs
incurred
relation
launch
new
cbd
products
lord
happy
brands
increased
general
administrative
expenses
driven
salaries
wages
support
company
growth
strategy
across
variety
functions
partially
offset
increase
gross
profit
conference
call
company
host
conference
call
live
audio
webcast
thursday
november
est
discuss
third
quarter
business
results
outlook
call
last
approximately
one
hour
audio
replay
call
archived
company
website
replay
instructions
conference
call
provided
live
audio
webcast
https
canada
international
conference
id
cronos
group
cronos
group
innovative
global
cannabinoid
company
international
production
distribution
across
five
continents
cronos
group
committed
building
disruptive
intellectual
property
advancing
cannabis
research
technology
product
development
passion
responsibly
elevate
consumer
experience
cronos
group
building
iconic
brand
portfolio
cronos
group
portfolio
includes
peace
naturals
global
health
wellness
platform
two
brands
cove
spinach
three
cbd
brands
lord
jones
happy
dance
information
cronos
group
brands
please
visit
statements
press
release
may
contain
information
may
constitute
information
statements
within
meaning
applicable
securities
laws
collectively
statements
based
upon
current
expectations
estimates
projections
assumptions
beliefs
information
clearly
historical
nature
may
constitute
statements
cases
statements
identified
use
terminology
expect
likely
may
intend
anticipate
potential
proposed
estimate
similar
words
expressions
phrases
including
negative
grammatical
variations
thereof
statements
certain
events
conditions
may
happen
discussion
strategy
statements
include
estimates
plans
expectations
opinions
forecasts
projections
targets
guidance
statements
statements
historical
fact
statements
include
limited
statements
respect
uncertainties
associated
pandemic
including
ability
abilities
joint
ventures
suppliers
distributors
effectively
deal
restrictions
limitations
health
issues
presented
pandemic
ability
continue
production
distribution
sale
products
demand
use
products
consumers
laws
regulations
amendments
thereto
applicable
business
impact
thereof
including
uncertainty
regarding
application
united
states
state
federal
law
hemp
including
cbd
products
scope
regulations
federal
drug
administration
federal
trade
commission
patent
trademark
office
state
equivalent
regulatory
agencies
hemp
including
cbd
products
expectations
regarding
regulation
hemp
industry
including
promulgation
regulations
hemp
industry
department
agriculture
grant
renewal
impact
license
supplemental
license
conduct
activities
cannabis
amendments
thereof
international
activities
joint
venture
interests
including
required
regulatory
approvals
licensing
anticipated
costs
timing
expected
impact
ability
successfully
create
launch
brands
create
launch
scale
consumer
products
including
acquisition
four
redwood
holding
group
llc
operating
subsidiaries
redwood
acquisition
cannabis
products
jurisdictions
products
legal
currently
operate
benefits
viability
safety
efficacy
dosing
social
acceptance
cannabis
including
cbd
cannabinoids
expectations
regarding
implementation
effectiveness
key
personnel
changes
anticipated
benefits
impact
altria
c
billion
approximately
billion
investment
us
altria
investment
potential
exercise
warrant
held
altria
rights
rights
connection
altria
investment
including
proceeds
us
may
result
therefrom
expectations
regarding
use
proceeds
equity
financings
including
proceeds
altria
investment
legalization
use
cannabis
medical
jurisdictions
outside
canada
related
timing
impact
thereof
intentions
participate
markets
use
legalized
expectations
regarding
potential
success
costs
benefits
associated
joint
ventures
strategic
alliances
equity
investments
including
strategic
partnership
ginkgo
bioworks
ability
execute
strategy
anticipated
benefits
strategy
expectations
amount
frequency
impairment
losses
including
result
intangible
assets
including
goodwill
ongoing
impact
legalization
additional
cannabis
product
types
forms
canada
including
federal
provincial
territorial
municipal
regulations
pertaining
thereto
related
timing
impact
thereof
intentions
participate
markets
future
performance
business
operations
competitive
advantages
business
strategies
competitive
conditions
industry
expected
growth
number
customers
using
products
ability
plans
identify
develop
commercialize
expand
technology
r
initiatives
cannabinoids
success
thereof
expectations
regarding
acquisitions
dispositions
anticipated
benefits
therefrom
including
redwood
acquisition
acquisition
certain
assets
apotex
fermentation
including
fermentation
manufacturing
facility
winnipeg
manitoba
proposed
sale
original
ogbc
production
facility
expectations
regarding
revenues
expenses
anticipated
cash
needs
expectations
regarding
cash
flow
liquidity
sources
funding
expectations
regarding
capital
expenditures
expansion
production
manufacturing
costs
timing
associated
therewith
receipt
applicable
production
sale
licenses
expected
growth
growing
production
supply
chain
capacities
expectations
regarding
resolution
litigation
legal
regulatory
proceedings
reviews
investigations
expectations
respect
future
production
costs
expectations
respect
future
sales
distribution
channels
expected
methods
used
distribute
sell
products
future
product
offerings
anticipated
future
gross
margins
operations
accounting
standards
estimates
ability
timely
effectively
remediate
material
weaknesses
internal
control
financial
reporting
expectations
regarding
distribution
network
expectations
regarding
costs
benefits
associated
contracts
agreements
third
parties
including
supply
manufacturing
agreements
certain
statements
contained
herein
concerning
industries
conduct
business
based
estimates
prepared
us
using
data
publicly
available
governmental
sources
market
research
industry
analysis
assumptions
based
data
knowledge
industries
believe
reasonable
however
although
generally
indicative
relative
market
positions
market
shares
performance
characteristics
data
inherently
imprecise
industries
conduct
business
involve
risks
uncertainties
subject
change
based
various
factors
described
statements
contained
herein
based
upon
certain
material
assumptions
applied
drawing
conclusion
making
forecast
projection
including
ability
abilities
joint
ventures
suppliers
distributors
effectively
deal
restrictions
limitations
health
issues
presented
pandemic
ability
continue
production
distribution
sale
products
customer
demand
use
products
ii
management
perceptions
historical
trends
current
conditions
expected
future
developments
iii
ability
generate
cash
flow
operations
iv
general
economic
financial
market
regulatory
political
conditions
operate
v
production
manufacturing
capabilities
output
facilities
joint
ventures
strategic
alliances
equity
investments
vi
consumer
interest
products
vii
competition
viii
anticipated
unanticipated
costs
ix
government
regulation
activities
products
including
limited
areas
taxation
environmental
protection
x
timely
receipt
required
regulatory
authorizations
approvals
consents
permits
licenses
xi
ability
obtain
qualified
staff
equipment
services
timely
manner
xii
ability
conduct
operations
safe
efficient
effective
manner
xiii
ability
realize
anticipated
benefits
synergies
generate
revenue
profits
value
recent
acquisitions
existing
operations
xiv
ability
complete
planned
dispositions
including
sale
ogbc
completed
obtain
anticipated
sales
price
xv
considerations
management
believes
appropriate
circumstances
management
considers
assumptions
reasonable
based
information
currently
available
management
assurance
expectations
prove
correct
nature
statements
subject
inherent
risks
uncertainties
may
general
specific
give
rise
possibility
expectations
forecasts
predictions
projections
conclusions
prove
accurate
assumptions
may
correct
objectives
strategic
goals
priorities
achieved
variety
factors
including
known
unknown
risks
many
beyond
control
could
cause
actual
results
differ
materially
statements
press
release
reports
file
furnish
sec
regulatory
agencies
made
directors
officers
employees
persons
authorized
speak
behalf
factors
include
without
limitation
risk
pandemic
may
disrupt
operations
suppliers
distribution
channels
negatively
impact
demand
use
products
risk
cost
savings
synergies
altria
investment
may
fully
realized
may
take
longer
realize
expected
risk
complete
planned
dispositions
including
sale
ogbc
completed
obtain
anticipated
sales
price
disruption
production
distribution
sales
result
pandemic
adverse
effects
pandemic
demand
use
products
implementation
effectiveness
key
personnel
changes
disruption
altria
investment
making
difficult
maintain
relationships
customers
employees
suppliers
future
levels
revenues
consumer
demand
cannabis
hemp
products
ability
manage
disruptions
credit
markets
changes
credit
rating
future
levels
capital
environmental
maintenance
expenditures
general
administrative
expenses
success
timing
completion
ongoing
anticipated
capital
maintenance
projects
business
strategies
growth
opportunities
expected
investment
adequacy
capital
resources
liquidity
including
limited
availability
sufficient
cash
flow
execute
business
plan
either
within
expected
timeframe
potential
effects
judicial
regulatory
proceedings
business
financial
condition
results
operations
cash
flows
volatility
degradation
general
economic
market
industry
business
conditions
compliance
applicable
environmental
economic
health
safety
energy
policies
regulations
particular
health
concerns
respect
vaping
use
cannabis
hemp
products
vaping
devices
anticipated
effects
actions
third
parties
competitors
activist
investors
federal
including
federal
state
provincial
territorial
local
regulatory
authorities
organizations
plaintiffs
litigation
persons
threatening
litigation
changes
regulatory
requirements
relation
business
products
factors
discussed
heading
risk
factors
company
annual
report
form
year
ended
december
amended
company
quarterly
report
form
quarterly
period
ended
september
readers
cautioned
consider
factors
uncertainties
potential
events
carefully
put
undue
reliance
statements
statements
provided
purposes
assisting
reader
understanding
financial
performance
financial
position
cash
flows
periods
ended
certain
dates
present
information
management
current
expectations
plans
relating
future
reader
cautioned
statements
may
appropriate
purpose
believe
assumptions
expectations
reflected
statements
reasonable
based
information
currently
available
management
assurance
assumptions
expectations
prove
correct
statements
made
date
made
based
beliefs
estimates
expectations
opinions
management
date
undertake
obligation
update
revise
statements
whether
result
new
information
estimates
opinions
future
events
results
otherwise
explain
material
difference
subsequent
actual
events
statements
statements
contained
press
release
reports
file
furnish
sec
regulatory
agencies
made
directors
officers
employees
persons
authorized
speak
behalf
expressly
qualified
entirety
cautionary
statements
used
press
release
cbd
means
cannabidiol
hemp
meaning
given
term
hemp
agricultural
improvement
act
including
cbd
cronos
group
condensed
consolidated
balance
sheets
september
december
thousands
dollars
except
share
amounts
unaudited
september
december
assets
current
assets
cash
cash
equivalents
investments
accounts
receivable
receivables
current
portion
loans
receivable
prepaids
assets
inventory
net
assets
total
current
assets
investments
equity
accounted
investees
advances
joint
ventures
loan
receivable
net
property
plant
equipment
assets
intangible
assets
goodwill
total
assets
liabilities
current
liabilities
accounts
payable
liabilities
current
portion
lease
obligation
derivative
liabilities
total
current
liabilities
due
interests
lease
obligation
total
liabilities
commitments
contingencies
ii
shareholders
equity
share
capital
iii
iv
additional
capital
retained
earnings
accumulated
comprehensive
income
loss
total
equity
attributable
shareholders
cronos
group
interests
total
shareholders
equity
total
liabilities
shareholders
equity
net
current
expected
credit
loss
allowance
september
december
ii
refer
note
note
notes
condensed
consolidated
financial
statements
form
period
ending
september
iii
authorized
issuance
september
unlimited
december
unlimited
iv
shares
issued
september
december
cronos
group
condensed
consolidated
statements
net
income
loss
comprehensive
income
loss
three
nine
months
ended
september
thousands
dollars
except
share
amounts
unaudited
three
months
ended
september
nine
months
ended
september
net
revenue
excise
taxes
excise
taxes
net
revenue
cost
sales
inventory
gross
profit
loss
operating
expenses
sales
marketing
research
development
r
general
administrative
payments
depreciation
amortization
total
operating
expenses
operating
loss
income
expense
interest
income
net
share
loss
investments
equity
accounted
investees
gain
revaluation
derivative
liabilities
financing
transaction
costs
impairment
loss
goodwill
intangible
assets
gain
disposal
investments
loss
reclassification
assets
income
loss
total
income
loss
income
loss
income
taxes
income
tax
expense
income
continuing
operations
income
loss
discontinued
operations
net
income
loss
net
income
loss
attributable
cronos
group
interests
comprehensive
income
loss
foreign
exchange
gain
loss
translation
total
comprehensive
income
loss
comprehensive
income
loss
comprehensive
income
loss
attributable
cronos
group
interests
net
income
loss
per
share
basic
continuing
operations
basic
discontinued
operations
diluted
continuing
operations
diluted
discontinued
operations
weighted
average
number
outstanding
shares
basic
diluted
computing
diluted
earnings
per
share
incremental
common
shares
considered
periods
net
loss
reported
inclusion
common
share
equivalents
would
cronos
group
condensed
consolidated
statements
cash
flows
nine
months
ended
september
thousands
dollars
except
share
amounts
unaudited
nine
months
ended
september
operating
activities
net
income
loss
items
affecting
cash
inventory
payments
depreciation
amortization
share
loss
investments
equity
accounted
investees
gain
revaluation
derivative
liabilities
gain
disposal
investments
impairment
loss
goodwill
intangible
assets
loss
gain
unrealized
foreign
exchange
provision
inventory
doubtful
accounts
sales
marketing
loss
reclassification
assets
net
net
changes
working
capital
cash
flows
used
operating
activities
investing
activities
purchase
investments
proceeds
disposal
investments
investments
equity
accounted
investees
proceeds
sale
investments
advances
joint
ventures
purchase
property
plant
equipment
payment
accrued
interest
construction
loan
payable
purchase
intangible
assets
acquisition
redwood
advances
loans
receivable
proceeds
repayment
loans
receivable
cash
assumed
acquisition
cash
flows
provided
used
investing
activities
financing
activities
advance
interests
repayment
lease
obligations
proceeds
altria
investment
proceeds
exercise
rights
proceeds
exercise
warrants
options
withholding
taxes
paid
equity
awards
share
issuance
costs
advance
loans
payable
repayment
loans
payable
transaction
costs
paid
construction
loan
payable
cash
flows
provided
used
financing
activities
effect
foreign
currency
translation
cash
cash
equivalents
net
change
cash
cash
equivalents
cash
cash
equivalents
beginning
period
cash
cash
equivalents
end
period
supplemental
cash
flow
information
interest
paid
interest
received
measures
addition
financial
results
reported
accordance
accounting
principles
generally
recognized
gaap
company
uses
certain
measures
recognized
gaap
adjusted
operating
loss
adjusted
operating
loss
business
segment
adjusted
earnings
interest
tax
depreciation
amortization
adjusted
ebitda
financial
measures
standardized
meaning
prescribed
gaap
therefore
unlikely
comparable
similar
measures
presented
companies
rather
measures
provided
supplement
gaap
measures
provide
additional
information
regarding
results
operations
management
perspective
accordingly
measures
considered
substitute
superior
financial
information
prepared
presented
accordance
gaap
measures
presented
press
release
reconciled
closest
reported
gaap
measure
reconciliations
historical
adjusted
financial
measures
corresponding
gaap
measures
provided
adjusted
operating
loss
management
reviews
operating
loss
adjusted
basis
excludes
certain
income
expense
items
management
believes
part
underlying
operations
items
typically
include
charges
review
costs
related
restatement
interim
financial
statements
management
view
items
part
underlying
results
may
highly
variable
may
infrequent
difficult
predict
distort
underlying
business
trends
results
management
believes
adjusted
operating
loss
provides
useful
insight
underlying
business
trends
results
provides
meaningful
comparison
results
management
uses
adjusted
operating
loss
planning
forecasting
evaluating
business
financial
performance
including
allocating
resources
evaluating
results
relative
employee
compensation
targets
thousands
dollars
three
months
ended
september
nine
months
ended
september
reported
operating
loss
adjustments
review
defense
costs
related
restatement
interim
financial
statements
adjusted
operating
loss
adjusted
operating
loss
business
segment
management
reviews
operating
loss
business
segment
excludes
corporate
expenses
adjusted
operating
loss
business
segment
excludes
certain
income
expense
items
management
believes
part
underlying
segment
operations
corporate
expenses
expenses
relate
consolidated
business
individual
operating
segment
income
expense
items
typically
include
charges
review
costs
related
restatement
interim
financial
statements
management
view
income
expense
items
part
underlying
results
segment
may
highly
variable
may
unusual
infrequent
difficult
predict
distort
underlying
business
trends
results
management
believes
adjusted
operating
loss
business
segment
provides
useful
insight
underlying
segment
trends
results
provide
meaningful
comparison
results
going
forward
management
uses
adjusted
operating
loss
business
segment
planning
forecasting
evaluating
segment
performance
including
allocating
resources
evaluating
results
relative
employee
compensation
thousands
dollars
three
months
ended
september
rest
world
total
segments
corporate
expenses
total
reported
operating
loss
adjustments
review
defense
costs
related
restatement
interim
financial
statements
adjusted
operating
loss
thousands
dollars
nine
months
ended
september
rest
world
total
segments
corporate
expenses
total
reported
operating
loss
adjustments
review
defense
costs
related
restatement
interim
financial
statements
adjusted
operating
loss
thousands
dollars
three
months
ended
september
rest
world
total
segments
corporate
expenses
total
reported
adjusted
operating
loss
thousands
dollars
nine
months
ended
september
rest
world
total
segments
corporate
expenses
total
reported
adjusted
operating
loss
adjusted
ebitda
adjusted
earnings
interest
tax
depreciation
amortization
adjusted
ebitda
used
management
supplemental
measure
review
assess
operating
performance
trends
comparable
basis
rest
industry
although
measure
adjusted
ebitda
may
directly
comparable
similar
measures
used
companies
management
reviews
ebitda
adjusted
basis
excludes
net
income
attributable
interests
special
items
special
items
consist
income
tax
recovery
expense
financing
transaction
costs
gains
losses
including
payments
item
unforeseeable
charges
management
described
thousands
dollars
three
months
ended
september
nine
months
ended
september
net
income
loss
adjustments
income
tax
expense
interest
income
net
share
loss
investments
equity
accounted
investees
gain
revaluation
derivative
liabilities
impairment
loss
goodwill
intangible
assets
financing
transaction
costs
income
loss
loss
reclassification
assets
gain
disposal
investments
loss
income
discontinued
operations
review
defense
costs
related
restatement
interim
financial
statements
payments
adjusted
ebit
adjustments
depreciation
amortization
adjusted
ebitda
special
items
management
view
following
special
items
part
underlying
results
may
highly
variable
may
infrequent
may
unpredictable
may
distort
underlying
business
results
trends
impairment
loss
goodwill
intangible
assets
nine
months
ended
september
company
recorded
million
impairment
charges
reporting
unit
million
impairment
charges
lord
brand
carrying
values
reporting
segment
goodwill
lord
brand
deemed
greater
fair
value
impairment
test
performed
results
operating
segment
negatively
impacted
effects
three
nine
months
ended
september
company
recorded
impairment
charges
goodwill
intangible
assets
financing
transaction
costs
three
nine
months
ended
september
financing
transaction
costs
million
three
nine
months
ended
september
company
recorded
charges
million
million
respectively
primarily
related
altria
investment
gain
loss
revaluation
derivative
liabilities
three
nine
months
ended
september
cronos
group
recorded
unrealized
gains
million
million
respectively
primarily
resulting
change
fair
value
financial
derivative
liabilities
associated
investment
altria
three
nine
months
ended
september
unrealized
gain
resulting
change
fair
value
financial
derivative
liabilities
million
million
respectively
review
costs
related
restatement
interim
financial
statements
three
nine
months
ended
september
company
incurred
million
million
respectively
review
costs
related
restatement
company
interim
financial
statements
costs
related
company
responses
reviews
restatement
various
regulatory
authorities
three
nine
months
ended
september
company
recorded
costs
related
restatement
previously
issued
financial
statements
gain
disposal
investments
three
nine
months
ended
september
company
recognized
gains
million
million
respectively
connection
receipt
aurora
cannabis
shares
achievement
milestones
related
company
sale
whistler
medical
marijuana
company
march
nine
months
ended
september
company
recorded
gain
disposal
investments
million
related
sale
aurora
cannabis
shares
connection
sale
whistler
medical
marijuana
company
well
sale
common
shares
canopy
growth
corporation
foreign
currency
exchange
rates
currency
amounts
press
release
stated
dollars
usd
reporting
currency
unless
otherwise
noted
references
dollars
usd
assets
liabilities
company
foreign
operations
translated
usd
exchange
rate
effect
september
december
transactions
affecting
shareholders
equity
translated
historical
foreign
exchange
rates
consolidated
statements
net
income
loss
comprehensive
income
loss
consolidated
statements
cash
flows
company
foreign
operations
translated
usd
applying
average
foreign
exchange
rate
effect
reporting
period
using
bloomberg
exchange
rates
used
translate
usd
canadian
dollars
c
shown
exchange
rates
shown
c
per
september
june
march
december
september
average
rate
spot
rate
average
rates
three
months
ended
average
rate
used
nine
months
ended
september
average
rate
used
nine
months
ended
september
